1. Agensys, Inc. (151 from 196 patents)

2. Abgenix, Inc. (14 from 32 patents)

3. Other (6 from 832,880 patents)

4. Japan Tobacco Inc. (5 from 1,040 patents)

5. University of California (4 from 15,502 patents)

6. Seattle Genetics, Inc. (4 from 132 patents)

7. Amgen Fremont Inc. (4 from 78 patents)

8. Genentech, Inc. (3 from 3,223 patents)

9. Seagen Inc. (3 from 64 patents)

10. Adicet Therapeutics, Inc. (3 from 4 patents)

11. Adicet Bio, Inc. (2 from 2 patents)

12. Harvard College (1 from 2,968 patents)

13. Amgen Inc. (1 from 1,975 patents)

14. Cell Genesys, Inc. (1 from 78 patents)

15. Xenotech, L.l.c. (1 from 9 patents)

1. 12371663 - Engineered γδ T-cells

2. 12364714 - Methods for selective expansion of gamma delta t-cell populations and compositions thereof

3. 12221480 - Methods for selective expansion of delta-3 gamma delta T-cell populations and compositions thereof

4. 11559582 - Antibody drug conjugates (ADC) that bind to 191P4D12 proteins

5. 11485785 - Antibodies capable of binding HLA-A2/TyrD in an HLA restricted manner and uses thereof

6. 11401347 - Antibodies and molecules derived therefrom that bind to STEAP-1 proteins

7. 11299708 - Methods for selective expansion of γδ T-cell populations and compositions thereof

8. 11135245 - Engineered γδ T-cells

9. 10894090 - Antibody drug conjugates (ADC) that bind to 191P4D12 proteins

10. RE48389 - Antibody drug conjugates (ADC) that bind to 191P4D12 proteins

11. 10597463 - Antibodies and molecules derived therefrom that bind to STEAP-1 proteins

12. 9962454 - Antibody drug conjugates (ADC) that bind to 191P4D12 proteins

13. 9617346 - Antibodies and molecules derived therefrom that bind to STEAP-1 proteins

14. 9593167 - Antibodies and immunoconjugates and uses therefor

15. 9314538 - Nucleic acid molecules encoding antibody drug conjugates (ADC) that bind to 191P4D12 proteins